TCL Archive Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial December 25, 2009
TCL Archive NCI Outlines Need For $3,873 Billion To Seize Cancer Research Opportunities October 30, 1998
TCL Archive Two Conflicting Studies Presented at ASCO 2013, FDA Called Upon To Sort Through The Data June 28, 2013
TCL Archive Wyngaarden Recommendation On New Director Due Nov. 1o; Five Staff Members Nominated November 4, 1988
TCL Archive Also AIDS Malignancy Consortium grants to be consolidated on recompetition to one central group chairman’s office. November 19, 2004
